Table 3.
Characteristics | HR | Lower 95% CI |
Upper 95% CI |
P |
---|---|---|---|---|
HER-2 positive vs hormone positive/HER-2 negative | 0.63 | 0.42 | 0.94 | .02 |
Triple negative vs hormone positive/HER-2 negative | 0.87 | 0.55 | 1.37 | .54 |
Stage I/II/III vs stage IV | 2.50 | 1.24 | 5.04 | .01 |
WBRT alone vs WBRT and surgery or radiosurgery | 0.67 | 0.40 | 1.13 | .13 |
No. of positive lymph nodes (>10 vs <10) | 1.99 | 1.15 | 3.42 | .01 |
Black race vs white/other | 1.41 | 0.85 | 2.34 | .18 |
RPA class III vs RPA class I/II | 3.47 | 2.35 | 5.14 | <.001 |
Radiation dose (<30 vs ≥30 Gy) | 3.41 | 1.56 | 7.50 | .002 |
|
HR indicates hazard ratio; CI, confidence interval; WBRT, whole brain radiotherapy; RPA, recursive partitioning analysis; Gy, grays.